Prudential Financial Inc. Has $2.29 Million Stake in Azenta, Inc. (NASDAQ:AZTA)

Prudential Financial Inc. lifted its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 164.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 45,868 shares of the company's stock after acquiring an additional 28,553 shares during the quarter. Prudential Financial Inc. owned approximately 0.10% of Azenta worth $2,293,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. State of Alaska Department of Revenue raised its stake in shares of Azenta by 355.2% during the 4th quarter. State of Alaska Department of Revenue now owns 25,899 shares of the company's stock worth $1,294,000 after purchasing an additional 20,210 shares in the last quarter. KLP Kapitalforvaltning AS bought a new stake in Azenta during the fourth quarter worth $530,000. Stephens Inc. AR acquired a new stake in Azenta in the fourth quarter valued at $313,000. SG Americas Securities LLC bought a new position in shares of Azenta in the 4th quarter valued at about $813,000. Finally, Conestoga Capital Advisors LLC increased its stake in shares of Azenta by 65.0% during the 4th quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock worth $78,894,000 after purchasing an additional 621,830 shares during the last quarter. 99.08% of the stock is owned by institutional investors and hedge funds.

Azenta Trading Down 8.6 %

AZTA stock traded down $2.51 during trading hours on Tuesday, hitting $26.59. 1,596,346 shares of the stock were exchanged, compared to its average volume of 620,936. The company has a 50-day simple moving average of $41.41 and a two-hundred day simple moving average of $45.29. The firm has a market capitalization of $1.22 billion, a P/E ratio of -8.92 and a beta of 1.66. Azenta, Inc. has a 12 month low of $26.14 and a 12 month high of $63.58.

Remove Ads

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, equities research analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AZTA. Needham & Company LLC raised their target price on shares of Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. TD Cowen raised Azenta to a "hold" rating in a report on Thursday, February 27th. Evercore ISI upped their price objective on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, Stephens reaffirmed an "overweight" rating and set a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.